Literature DB >> 30517621

Unlocking the potential of value-based health care by defining global standard sets of outcome measures that matter to patients with cardiovascular diseases.

William H Seligman1, Matthew Salt1, Alethse De la Torre Rosas1, Zofia Das-Gupta1.   

Abstract

As health systems around the world increasingly look to record and improve the value of care that they provide to patients, being able to measure the outcomes that matter most to patients is vital. Clinicians today gather more data than ever before, but what is measured often has little relationship to the results of care that matter most to patients. Through its working groups of global experts in particular diseases, the International Consortium for Health Outcomes Measurement aims to define minimum Standard Sets of outcomes, along with case-mix factors to support risk adjustment and meaningful comparison. These Standard Sets may then be implemented globally empowering patients to select providers with the best outcomes at the lowest cost, empowering providers that deliver superior outcomes at competitive costs to excel, and empowering payers to negotiate contracts based on results. The International Consortium for Health Outcomes Measurement has published 24 Standard Sets including coronary artery disease, heart failure, hypertension, and stroke and is nearing the completion of its work in atrial fibrillation. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Outcomes; Patient-reported; Value-based health care

Mesh:

Year:  2019        PMID: 30517621     DOI: 10.1093/ehjqcco/qcy056

Source DB:  PubMed          Journal:  Eur Heart J Qual Care Clin Outcomes        ISSN: 2058-1742


  3 in total

Review 1.  Challenges to Global Standardization of Outcome Measures.

Authors:  Zoe Liao; Yuri Quintana
Journal:  AMIA Jt Summits Transl Sci Proc       Date:  2021-05-17

2.  Developing process measures in value-based healthcare: the case of aortic valve disease.

Authors:  Berdel Akmaz; Nina Zipfel; Roland A Bal; Benno J W M Rensing; Edgar J Daeter; Paul B van der Nat
Journal:  BMJ Open Qual       Date:  2019-11-07

3.  Quality of vision and vision-related quality of life after Descemet membrane endothelial keratoplasty: a randomized clinical trial.

Authors:  Suryan L Dunker; Mor M Dickman; Robert P L Wisse; Siamak Nobacht; Robert H J Wijdh; Marjolijn C Bartels; N E Mei-Lie Tang; Frank J H M van den Biggelaar; Pieter J Kruit; Bjorn Winkens; Rudy M M A Nuijts
Journal:  Acta Ophthalmol       Date:  2021-01-12       Impact factor: 3.761

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.